http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019098759-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13dff6a3f7b26356582ff2bcee722a3c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102
filingDate 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a660f6df25a3df33d5ffeb6e6a37f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860aa0305c210ed69aefc8b1aac0c125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86193c5729031c1383bd0e4dbb474f83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a49b8cc2b76983c89111440d47bc787a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c9d2820817ff037c42d1347bcecd7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e9cbc5108fc29d6757d9c79903088ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c327bfe6fb1dc05eac5c6db60b14387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d15269487c4216b5f0cecec9ea2daa9
publicationDate 2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019098759-A2
titleOfInvention Transformed human cell and use thereof
abstract The present invention relates to a transformed human cell and a use thereof and, more particularly, to a cell transformed with a gene for coding an MHC I cell membrane receptor and an MHC II cell membrane receptor by using a gene expression suppressing system using a guide RNA, and a use thereof. Such a transformed cell can effectively exhibit the therapeutic effect of cells even in vivo , and cannot be removed by an in vivo immune response. Therefore, it is expected that a composition comprising the immunocyte as an active ingredient can be usefully used for the treatment of cancer, infectious diseases, degenerative diseases or immunological diseases.
priorityDate 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466138719

Total number of triples: 35.